BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ER, estrogen receptor AND Treatment
168 results:

  • 1. Pancreas Β-Cells in Type 1 and Type 2 Diabetes: Cell Death, Oxidative Stress and Immune Regulation. Recently Appearing Changes in Diabetes Consequences.
    Novoselova EG; Lunin SM; Khrenov MO; Glushkova OV; Novoselova TV; Parfenyuk SB
    Cell Physiol Biochem; 2024 Apr; 58(2):144-155. PubMed ID: 38639210
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Nomogram model for predicting early recurrence for resectable pancreatic cancer: A multicenter study.
    Man Q; Pang H; Liang Y; Chang S; Wang J; Gao S
    Medicine (Baltimore); 2024 Mar; 103(10):e37440. PubMed ID: 38457597
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Unfolded Protein-Based Sandwich AIE Probe Imparts High Fluorescent Contrast for Pan-cancer Surgical Navigation.
    Wang Q; Chen B; Duan C; Wang T; Lou X; Dai J; Xia F
    Anal Chem; 2024 Feb; 96(8):3609-3617. PubMed ID: 38364862
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ER-positive and BRCA2-mutated breast cancer: a literature review.
    Li PC; Zhu YF; Cao WM; Li B
    Eur J Med Res; 2024 Jan; 29(1):30. PubMed ID: 38184581
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization.
    Liu H; Guo H; Wu Y; Hu Q; Hu G; He H; Yin Y; Nan X; Lin G; Han J; Zhao R; Liu Y
    Sci Rep; 2023 Dec; 13(1):21488. PubMed ID: 38057406
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pan-Inhibition of Protein Disulfide Isomerase Caused Cell Death through Disrupting Cellular Proteostasis in pancreatic Ductal Adenocarcinoma Cells.
    Hung CS; Lee KL; Huang WJ; Su FH; Liang YC
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003657
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Actinomycin D synergizes with Doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis.
    Yang H; Li S; Li W; Yang Y; Zhang Y; Zhang S; Hao Y; Cao W; Xu F; Wang H; Du G; Wang J
    Carcinogenesis; 2024 Apr; 45(4):262-273. PubMed ID: 37997385
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. An innovative nanoformulation utilizing tumor microenvironment-responsive PEG-polyglutamic coating and dynamic charge adjustment for specific targeting of ER stress inducer, microRNA, and immunoadjuvant in pancreatic cancer: In vitro investigations.
    Li CY; Chou TF; Lo YL
    Int J Biol Macromol; 2024 Jan; 254(Pt 2):127905. PubMed ID: 37939778
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Apoptotic Effect of Gallic Acid via Regulation of p-p38 and ER Stress in PANC-1 and MIA PaCa-2 Cells pancreatic cancer Cells.
    Kim JW; Choi J; Park MN; Kim B
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894916
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Exploring dual effects of dinutuximab beta on cell death and proliferation of insulinoma.
    Karatug Kacar A
    Chem Biol Drug Des; 2024 Jan; 103(1):e14368. PubMed ID: 37802653
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cells.
    Kopecka J; Barbanente A; Vitone D; Arnesano F; Margiotta N; Berchialla P; Niso M; Riganti C; Abate C
    Pharmacol Rep; 2023 Dec; 75(6):1588-1596. PubMed ID: 37796435
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks.
    Li C; Xie Y; Hu S; Yu H; Xu Y; Shen H; Yuan Y; Gu L; Pu B
    Chem Biol Drug Des; 2024 Jan; 103(1):e14363. PubMed ID: 37793997
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Shared decision making with Oncologists and Palliative care specialists (SOP) model help advanced pancreatic cancer patients reaching goal concordant care: A prospective cohort study.
    Tseng YL; Lin YC; Hsu WJ; Kang YC; Su HY; Cheng SY; Tsai JS; Chiu TY; Huang HL
    Cancer Med; 2023 Oct; 12(19):20119-20128. PubMed ID: 37740620
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Combination of RUNX1 inhibitor and gemcitabine mitigates chemo-resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress.
    She C; Wu C; Guo W; Xie Y; Li S; Liu W; Xu C; Li H; Cao P; Yang Y; Wang X; Chang A; Feng Y; Hao J
    J Exp Clin Cancer Res; 2023 Sep; 42(1):238. PubMed ID: 37697370
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ERCC6L facilitates the onset of mammary neoplasia and promotes the high malignance of breast cancer by accelerating the cell cycle.
    Yang H; Zhen X; Yang Y; Zhang Y; Zhang S; Hao Y; Du G; Wang H; Zhang B; Li W; Wang J
    J Exp Clin Cancer Res; 2023 Sep; 42(1):227. PubMed ID: 37667329
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A new scoring system with simple preoperative parameters as predictors of early recurrence of pancreatic ductal adenocarcinoma.
    Shimagaki T; Sugimachi K; Mano Y; Tomino T; Onishi E; Nakashima Y; Sugiyama M; Yamamoto M; Morita M; Shimokawa M; Yoshizumi T; Toh Y
    PLoS One; 2023; 18(7):e0288033. PubMed ID: 37450554
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Konjac glucomannan enhances 5-FU-induced cytotoxicity of hepatocellular carcinoma cells via TLR4/PERK/CHOP signaling to induce endoplasmic reticulum stress.
    Shi Y; Ma J; Chen KE; Chen B
    Oncol Res; 2022; 30(4):201-210. PubMed ID: 37304412
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Early Recurrence after Upfront Surgery for pancreatic Ductal Adenocarcinoma.
    Nappo G; Donisi G; Capretti G; Ridolfi C; Pagnanelli M; Nebbia M; Bozzarelli S; Petitti T; Gavazzi F; Zerbi A
    Curr Oncol; 2023 Mar; 30(4):3708-3720. PubMed ID: 37185395
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A novel combined carbohydrate antigen 19-9 and lymphocyte-to-monocyte ratio score can predict early recurrence of resectable pancreatic ductal adenocarcinoma.
    Yugawa K; Maeda T; Nagata S; Sakai A; Taketani K; Yamaguchi S; Konishi K; Hashimoto K
    Surg Today; 2023 Oct; 53(10):1199-1208. PubMed ID: 36943449
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A liquid biopsy signature for predicting early recurrence in patients with gastric cancer.
    Okuno K; Watanabe S; Roy S; Kanda M; Tokunaga M; Kodera Y; Kinugasa Y; Goel A
    Br J Cancer; 2023 Apr; 128(6):1105-1116. PubMed ID: 36631634
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.